10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,590 | -28.0% | 18,584 | -2.6% | 0.02% | -30.3% |
| Q2 2023 | $1,065,204 | +0.1% | 19,076 | -0.0% | 0.03% | -10.8% |
| Q1 2023 | $1,064,306 | +67.9% | 19,077 | +9.7% | 0.04% | +42.3% |
| Q4 2022 | $633,837 | -19.8% | 17,394 | -0.4% | 0.03% | -29.7% |
| Q2 2022 | $790,000 | +237.6% | 17,461 | +468.4% | 0.04% | +236.4% |
| Q1 2022 | $234,000 | +8.3% | 3,072 | +179.0% | 0.01% | -52.2% |
| Q2 2021 | $216,000 | – | 1,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |